{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:58:31Z","timestamp":1791266311063,"version":"4.1.0"},"reference-count":252,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bbcan.2014.01.008","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T06:46:07Z","timestamp":1391323567000},"page":"232-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma"],"prefix":"10.1016","volume":"1845","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-0835","authenticated-orcid":false,"given":"Leonardo Vin\u00edcius Monteiro","family":"de Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamille","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro C\u00e9sar","family":"Isoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2014.01.008_bb0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1258\/jrsm.98.10.455","article-title":"Mesothelioma: time to take stock","volume":"98","author":"Tan","year":"2005","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0010","first-page":"356","article-title":"Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century","volume":"11","author":"Becklake","year":"2007","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0015","first-page":"70","article-title":"Mesothelioma: a review","volume":"12","author":"Mott","year":"2012","journal-title":"Ochsner J."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0020","series-title":"Malignant Mesothelioma","first-page":"149","article-title":"Genetics and molecular biology of mesothelioma","volume":"vol. 189","author":"Fennell","year":"2012"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","article-title":"Mesothelioma epidemiology, carcinogenesis, and pathogenesis","volume":"9","author":"Yang","year":"2008","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0030","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0035","first-page":"260","article-title":"Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province","volume":"17","author":"Wagner","year":"1960","journal-title":"Br. J. Ind. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0040","series-title":"Public Health Statement for Asbestos","author":"ATSDR","year":"2001"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0045","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1158\/0008-5472.CAN-04-2461","article-title":"Evidence against a role for SV40 in human mesothelioma","volume":"65","author":"Manfredi","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0050","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/096032719201100615","article-title":"Intrapleural administration of fibres induces mesothelioma in rats in the same relative order of hazard as occurs in man after exposure","volume":"11","author":"Carthew","year":"1992","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","article-title":"Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma","volume":"206","author":"Cheung","year":"2013","journal-title":"Cancer Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jnci\/92.8.636","article-title":"Adenovirus-mediated p14ARF gene transfer in human mesothelioma cells","volume":"92","author":"Yang","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0065","first-page":"511","article-title":"Codeletion of p15 and p16 in primary malignant mesothelioma","volume":"11","author":"Xio","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0070","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.lungcan.2005.03.017","article-title":"Implications of P16\/CDKN2A deletion in pleural mesotheliomas","volume":"49","author":"Ladanyi","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular changes in mesothelioma with an impact on prognosis and treatment","volume":"136","author":"Jean","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0080","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1073\/pnas.0912203107","article-title":"The Hippo\u2013Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis","volume":"107","author":"Lee","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drup.2012.10.001","article-title":"From tumor prevention to therapy: empowering p53 to fight back","volume":"15","author":"Frezza","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1349-7006.2009.01336.x","article-title":"Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells","volume":"101","author":"Sekido","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yexmp.2012.04.001","article-title":"Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients","volume":"93","author":"Bahnassy","year":"2012","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/02841860500468927","article-title":"Expression of bcl-2 family members in malignant pleural mesothelioma","volume":"45","author":"O'Kane","year":"2006","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0105","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0110","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1038\/sj.onc.1208744","article-title":"Human and mouse mesotheliomas exhibit elevated AKT\/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0115","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1165\/rcmb.2007-0460OC","article-title":"mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids","volume":"39","author":"Wilson","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0125","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1158\/0008-5472.CAN-10-2164","article-title":"LATS2 is a tumor suppressor gene of malignant mesothelioma","volume":"71","author":"Murakami","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0130","first-page":"181","article-title":"Activation of the PI3K-AKT pathway in human malignant mesothelioma cells","volume":"2","author":"Suzuki","year":"2009","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0135","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/cncr.22552","article-title":"Update on the molecular biology of malignant mesothelioma","volume":"109","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0140","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.lungcan.2006.08.012","article-title":"EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma","volume":"54","author":"Edwards","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0150","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/path.824","article-title":"Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma","volume":"193","author":"Strizzi","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0155","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/j.lungcan.2004.04.022","article-title":"Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma","volume":"45","author":"Kindler","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0160","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/jnci\/87.24.1870","article-title":"Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma","volume":"87","author":"Kratzke","year":"1995","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0959-437X(02)00013-8","article-title":"Tumor suppression by Ink4a-Arf: progress and puzzles","volume":"13","author":"Lowe","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF00195777","article-title":"Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium","volume":"424","author":"Segers","year":"1994","journal-title":"Virchows Arch."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0175","first-page":"3508","article-title":"Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma","volume":"5","author":"Soini","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ijc.11209","article-title":"Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment","volume":"106","author":"Hopkins-Donaldson","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0185","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.210773.112","article-title":"The Hippo pathway: regulators and regulations","volume":"27","author":"Yu","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0190","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1038\/onc.2012.5","article-title":"YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes","volume":"31","author":"Mizuno","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-\u03b2 synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth","volume":"209","author":"Fujii","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977194.2012.752737","article-title":"The way Wnt works: components and mechanism","volume":"31","author":"Saito-Diaz","year":"2013","journal-title":"Growth Factors"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0205","first-page":"4547","article-title":"Wnt pathway activation in mesothelioma: evidence of dishevelled overexpression and transcriptional activity of \u00ce2-catenin","volume":"63","author":"Uematsu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0210","first-page":"1","article-title":"The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms","author":"de Assis","year":"2013","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0215","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.0604544103","article-title":"Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters","volume":"103","author":"Kroczynska","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0220","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/sj.onc.1206552","article-title":"New developments about the association of SV40 with human mesothelioma","volume":"22","author":"Carbone","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0225","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1097-4644(20000201)76:2<181::AID-JCB2>3.0.CO;2-9","article-title":"Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations","volume":"76","author":"Shivapurkar","year":"1999","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0230","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(04)17102-X","article-title":"Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids","volume":"364","author":"Lopez-Rios","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0235","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/030089161209800205","article-title":"Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy","volume":"98","author":"Comar","year":"2012","journal-title":"Tumori"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1014321729038","article-title":"Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium)","volume":"13","author":"Hubner","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0245","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4132\/KoreanJPathol.2013.47.2.124","article-title":"No detection of simian virus 40 in malignant mesothelioma in Korea","volume":"47","author":"Eom","year":"2013","journal-title":"Kor. J. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0250","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/030089161009600504","article-title":"No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia","volume":"96","author":"Hmeljak","year":"2010","journal-title":"Tumori"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0255","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1586\/ers.11.51","article-title":"Simian virus 40 transformation, malignant mesothelioma and brain tumors","volume":"5","author":"Qi","year":"2012","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0260","first-page":"1524","article-title":"SV40 induces mesotheliomas in hamsters","volume":"142","author":"Cicala","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0265","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1158\/0008-5472.CAN-05-4668","article-title":"A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent","volume":"66","author":"Robinson","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2014.01.008_bb0270","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/carcin\/bgt322","article-title":"Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance","volume":"35","author":"Cleaver","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.onc.1206097","article-title":"Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells","volume":"22","author":"Bocchetta","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0280","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/0008-5472.CAN-07-5203","article-title":"The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth","volume":"68","author":"Bocchetta","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0285","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1038\/sj.onc.1205382","article-title":"Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen","volume":"25","author":"Catalano","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0290","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/sj.onc.1205203","article-title":"SV40 infection induces telomerase activity in human mesothelial cells","volume":"21","author":"Foddis","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0295","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1158\/0008-5472.CAN-05-3727","article-title":"SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells","volume":"67","author":"Pietruska","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0300","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.bjc.6604879","article-title":"Occupational, domestic and environmental mesothelioma risks in the British population: a case\u2013control study","volume":"100","author":"Rake","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/08958379209145671","article-title":"Relative mesothelioma induction in rats by mineral fibers: comparison with residual pulmonary mineral fiber number and epidemiology","volume":"4","author":"Coffin","year":"1992","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0310","first-page":"420","article-title":"Zeolite bodies in human lungs from Turkey","volume":"44","author":"Sebastien","year":"1981","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0315","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ijc.2910390104","article-title":"Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey","volume":"39","author":"Baris","year":"1987","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/oem.58.4.261","article-title":"Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzk\u00f6y, Cappadocia, Turkey","volume":"58","author":"Dumortier","year":"2001","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0325","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1420326X08099908","article-title":"First confirmed erionite related mesothelioma in North America","volume":"17","author":"Ilgren","year":"2008","journal-title":"Indoor Built Environ."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0330","first-page":"407","article-title":"North American erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: a case report","volume":"2","author":"Kliment","year":"2009","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"33","key":"10.1016\/j.bbcan.2014.01.008_bb0335","doi-asserted-by":"crossref","first-page":"13611","DOI":"10.1073\/pnas.1105887108","article-title":"Erionite exposure in North Dakota and Turkish villages with mesothelioma","volume":"108","author":"Carbone","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0340","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1158\/0008-5472.CAN-11-3481","article-title":"Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma","volume":"72","author":"Jube","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0345","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1078-0432.CCR-11-2259","article-title":"Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma","volume":"18","author":"Carbone","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0350","first-page":"173","article-title":"Interleukin-1beta and tumour necrosis factor-alpha promote the transformation of human immortalised mesothelial cells by erionite","volume":"25","author":"Wang","year":"2004","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.bbcan.2014.01.008_bb0355","first-page":"1","article-title":"Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells","volume":"C7\u201339","author":"Hillegass","year":"2013","journal-title":"Part Fibre Toxicol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0360","first-page":"F115","article-title":"The p16INK4a\/CDKN2A tumor suppressor and its relatives","volume":"1378","author":"Ruas","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0365","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.molcel.2012.03.027","article-title":"TGF-beta-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217\/CoREST complex","volume":"46","author":"Thillainadesan","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0370","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nature06084","article-title":"p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a","volume":"448","author":"Krimpenfort","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0375","first-page":"235","article-title":"Detecting homozygous deletions in the CDKN2A(p16INK4a)\/ARF(p14ARF) gene in urinary bladder cancer using real-time quantitative PCR","volume":"9","author":"Berggren","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0380","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/01.ju.0000067626.37837.3e","article-title":"Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer","volume":"170","author":"Chang","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0385","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.0022-202X.2004.22501.x","article-title":"p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma","volume":"122","author":"Brown","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0390","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/modpathol.3800308","article-title":"p16INK4A and p14ARF expression pattern by immunohistochemistry in human papillomavirus-related cervical neoplasia","volume":"18","author":"Wang","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0395","first-page":"5547","article-title":"p16 Alterations and deletion mapping of 9p21\u2013p22 in malignant mesothelioma","volume":"54","author":"Cheng","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0400","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0405","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cncr.23413","article-title":"9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA\u2013ICM, and AgNOR analysis","volume":"114","author":"Onofre","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/jclinpath-2011-200208","article-title":"Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues","volume":"65","author":"Takeda","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0415","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/modpathol.2008.45","article-title":"Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas","volume":"21","author":"Chiosea","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","article-title":"Promoter methylation of RASSF1A, RAR\u00ce2 and DAPK predict poor prognosis of patients with malignant mesothelioma","volume":"54","author":"Fischer","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0425","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0430","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35092592","article-title":"Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis","volume":"413","author":"Sharpless","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0435","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0440","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1073\/pnas.0808816106","article-title":"Activated TNF-alpha\/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice","volume":"106","author":"Altomare","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0445","doi-asserted-by":"crossref","first-page":"e18828","DOI":"10.1371\/journal.pone.0018828","article-title":"Losses of both products of the Cdkn2a\/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis","volume":"6","author":"Altomare","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0450","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1038\/sj.onc.1201870","article-title":"Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression","volume":"16","author":"Frizelle","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0455","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.cgt.7700241","article-title":"Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus","volume":"7","author":"Frizelle","year":"2000","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0460","first-page":"33","article-title":"A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells","volume":"23","author":"Yang","year":"2003","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0465","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2013\/572609","article-title":"A potential therapeutic strategy for malignant mesothelioma with gene medicine","volume":"2013","author":"Tada","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0470","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/GIM.0b013e3181ac9a27","article-title":"Neurofibromatosis 2 [bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]","volume":"11","author":"Evans","year":"2009","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0475","first-page":"1227","article-title":"Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer","volume":"55","author":"Sekido","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0480","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0485","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/mutage\/get008","article-title":"Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma","volume":"28","author":"Andujar","year":"2013","journal-title":"Mutagenesis"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0490","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cancergen.2012.08.005","article-title":"Heterozygous loss of NF2 is an early molecular alteration in well-differentiated papillary mesothelioma of the peritoneum","volume":"205","author":"Nemoto","year":"2012","journal-title":"Cancer Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0495","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/gcc.20669","article-title":"CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma\u2014a miRNA microarray analysis","volume":"48","author":"Guled","year":"2009","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0500","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2008.01.030","article-title":"A conditional mouse model for malignant mesothelioma","volume":"13","author":"Jongsma","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0505","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3171\/jns.1999.91.1.0085","article-title":"Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer","volume":"91","author":"Ikeda","year":"1999","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0510","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hmg\/11.1.69","article-title":"Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis","volume":"11","author":"Schulze","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0515","first-page":"1493","article-title":"Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation","volume":"2003","author":"Fraenzer","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0520","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/neuonc\/nop060","article-title":"Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma","volume":"12","author":"Morales","year":"2010","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0525","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1038\/sj.onc.1209587","article-title":"Re-expression of the tumor suppressor NF2\/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK","volume":"25","author":"Poulikakos","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0530","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","article-title":"The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression","volume":"25","author":"Xiao","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0535","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(00)04013-7","article-title":"Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey","volume":"357","author":"Roushdy-Hammady","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0540","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1158\/0008-5472.CAN-05-4642","article-title":"Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey","volume":"66","author":"Dogan","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0545","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/19338240903390305","article-title":"Endemic malignant mesothelioma: exposure to erionite is more important than genetic factors","volume":"65","author":"Metintas","year":"2010","journal-title":"Arch. Environ. Occup. Health"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0550","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0555","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0560","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0565","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0570","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/JTO.0b013e31829e7ef9","article-title":"Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations","volume":"8","author":"Zauderer","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0575","first-page":"1","article-title":"BAP1 protein is a progression factor in malignant pleural mesothelioma","author":"Arzt","year":"2013","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0580","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.bbcan.2014.01.008_bb0585","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2013","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0590","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1101\/gad.9.5.534","article-title":"The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation","volume":"9","author":"Justice","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0595","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/geno.1999.6065","article-title":"Structure, expression, and chromosome mapping of LATS2, a mammalian homologue of the Drosophila tumor suppressor gene lats\/warts","volume":"63","author":"Yabuta","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0600","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/gcc.20247","article-title":"Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11","volume":"44","author":"Chen","year":"2005","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0605","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1101\/gad.1447006","article-title":"A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization","volume":"20","author":"Aylon","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0610","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1101\/gad.1954410","article-title":"The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1","volume":"24","author":"Aylon","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0615","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.4161\/cc.9.19.13386","article-title":"LATS tumor suppressor: a new governor of cellular homeostasis","volume":"9","author":"Visser","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0620","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0625","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0630","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2006.06.017","article-title":"Promoter methylation of RASSF1A, RAR\u03b2 and DAPK predict poor prognosis of patients with malignant mesothelioma","volume":"54","author":"Fischer","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0635","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2013.05.014","article-title":"The role of epigenetics in malignant pleural mesothelioma","volume":"81","author":"Vandermeers","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0640","doi-asserted-by":"crossref","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Ivanov","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bbcan.2014.01.008_bb0645","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0650","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/ijc.25285","article-title":"Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma","volume":"127","author":"Gee","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1265","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/JTO.0b013e3182572e83","article-title":"Increased circulating miR-625\u20133p: a potential biomarker for patients with malignant pleural mesothelioma","volume":"7","author":"Kirschner","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.bbcan.2014.01.008_bb0655","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.lungcan.2013.09.017","article-title":"The degree of microRNA-34b\/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma","volume":"82","author":"Muraoka","year":"2013","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0660","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","author":"Cioce","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0665","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(02)00824-3","article-title":"salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines","volume":"110","author":"Tapon","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0670","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1073\/pnas.0911427107","article-title":"Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver","volume":"107","author":"Lu","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0675","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1038\/sj.onc.1204557","article-title":"Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion","volume":"20","author":"Shigemitsu","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0680","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1038\/sj.onc.1206533","article-title":"Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion","volume":"22","author":"Usami","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbcan.2014.01.008_bb0685","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jtcvs.2013.08.035","article-title":"Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro","volume":"147","author":"You","year":"2013","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0690","doi-asserted-by":"crossref","first-page":"e66685","DOI":"10.1371\/journal.pone.0066685","article-title":"Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma","volume":"8","author":"Lim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0695","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cancergen.2013.04.006","article-title":"Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines","volume":"206","author":"Klorin","year":"2013","journal-title":"Cancer Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0700","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2119\/molmed.2012.00077","article-title":"Circadian rhythm disruption in cancer biology","volume":"18","author":"Savvidis","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0705","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.ede.0000152525.21924.54","article-title":"Circadian disruption and breast cancer: from melatonin to clock genes","volume":"16","author":"Stevens","year":"2005","journal-title":"Epidemiology"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0710","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1200\/JCO.2006.06.1440","volume":"24","author":"Giacchetti","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0715","doi-asserted-by":"crossref","first-page":"e6554","DOI":"10.1371\/journal.pone.0006554","article-title":"Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype","volume":"4","author":"R\u00f8e","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0720","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/ijc.27598","article-title":"The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma","volume":"131","author":"Elshazley","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0725","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/JTO.0b013e318215a07d","article-title":"Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy","volume":"6","author":"Brevet","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0730","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0735","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ctrv.2010.11.004","article-title":"Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand?","volume":"37","author":"Agarwal","year":"2011","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0740","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/thx.2007.085241","article-title":"EGFR and PDGFR differentially promote growth in malignant epithelioid mesothelioma of short and long term survivors","volume":"63","author":"Kothmaier","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0745","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","article-title":"EGFR overexpression in malignant pleural mesothelioma: an immunohistochemical and molecular study with clinico-pathological correlations","volume":"51","author":"Destro","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0750","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","article-title":"Gefitinib in patients with malignant mesothelioma: a phase II study by the cancer and leukemia group B","volume":"11","author":"Govindan","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0755","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of Erlotinib in patients with malignant pleural mesothelioma: a southwest oncology group study","volume":"25","author":"Garland","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0760","first-page":"2063","article-title":"Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma","volume":"18","author":"Linder","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0765","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0","article-title":"Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression","volume":"189","author":"Kumar-Singh","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0770","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1378\/chest.128.5.3382","article-title":"Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma*","volume":"128","author":"Demirag","year":"2005","journal-title":"Chest J."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0775","first-page":"4833","article-title":"Expression of vascular endothelial growth factor in malignant mesothelioma","volume":"26","author":"Aoe","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0780","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1476-5381.2012.01873.x","article-title":"Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma","volume":"166","author":"Favoni","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0785","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/cncr.23617","article-title":"Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma","volume":"113","author":"Jackman","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0790","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.canlet.2005.08.010","article-title":"Molecular pathways in malignant pleural mesothelioma","volume":"239","author":"Whitson","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0795","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1378\/chest.125.5.1843","article-title":"Gene expression profiling identifies matriptase overexpression in malignant mesothelioma","volume":"125","author":"Hoang","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0800","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1158\/0008-5472.CAN-04-1898","article-title":"Selective activation of insulin receptor substrate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes","volume":"64","author":"Hoang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0805","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/ijc.27471","article-title":"Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites\/cell","volume":"131","author":"Kalra","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0810","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0815","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"microRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0820","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2559.2000.00888.x","article-title":"Immunoreactivity for cadherins, HGF\/SF, met, and erbB-2 in pleural malignant mesotheliomas","volume":"36","author":"Thirkettle","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0825","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/0008-5472.CAN-04-4567","article-title":"Functional analysis of c-Met\/hepatocyte growth factor pathway in malignant pleural mesothelioma","volume":"66","author":"Jagadeeswaran","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0830","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/carcin\/bgp097","article-title":"Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells","volume":"30","author":"Kawaguchi","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0835","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1158\/1078-0432.CCR-05-1191","article-title":"Inhibition of the Met receptor in mesothelioma","volume":"11","author":"Mukohara","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0840","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Res."},{"issue":"13","key":"10.1016\/j.bbcan.2014.01.008_bb0845","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1093\/nar\/gkr154","article-title":"Evolutionary expansion of the Ras switch regulatory module in eukaryotes","volume":"39","author":"D\u00edez","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0850","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0855","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4161\/cc.8.8.8147","article-title":"How ERK1\/2 activation controls cell proliferation and cell death: is subcellular localization the answer?","volume":"8","author":"Mebratu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0860","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0865","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1369\/jhc.5A6807.2006","article-title":"Phosphorylated extracellular signal-regulated kinases are significantly increased in malignant mesothelioma","volume":"54","author":"Melo","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0870","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/cncr.21014","article-title":"Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells","volume":"103","author":"Vintman","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0875","first-page":"5334","article-title":"Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor","volume":"56","author":"Zanella","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0880","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0002-9440(10)63867-9","article-title":"Persistent localization of activated extracellular signal-regulated kinases (ERK1\/2) is epithelial cell-specific in an inhalation model of asbestosis","volume":"162","author":"Cummins","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0885","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ijc.25763","article-title":"ERK2 is essential for the growth of human epithelioid malignant mesotheliomas","volume":"129","author":"Shukla","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0890","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","article-title":"Cellular function of phosphoinositide 3-kinases: implications for development, immunity, homeostasis, and cancer","volume":"17","author":"Katso","year":"2001","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0895","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0900","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0905","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/carcin\/bgp258","article-title":"Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk","volume":"30","author":"Chen","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0910","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1038\/onc.2008.245","article-title":"PI3K pathway alterations in cancer: variations on a theme","volume":"27","author":"Yuan","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0915","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0920","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.semcdb.2003.12.022","article-title":"PDK1, the master regulator of AGC kinase signal transduction","volume":"15","author":"Mora","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0925","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/labinvest.2010.133","article-title":"Expanding therapeutic targets in bladder cancer: the PI3K\/Akt\/mTOR pathway","volume":"90","author":"Ching","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0930","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0955-0674(98)80150-6","article-title":"The mRNA 5\u2032 cap-binding protein eIF4E and control of cell growth","volume":"10","author":"Sonenberg","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0935","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(97)00323-2","article-title":"The modular phosphorylation and activation of p70s6k","volume":"410","author":"Pullen","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0940","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/1535-7163.MCT-04-0243","article-title":"Human mesothelioma cells exhibit tumor cell-specific differences in phosphatidylinositol 3-kinase\/AKT activity that predict the efficacy of Onconase","volume":"4","author":"Ramos-Nino","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0945","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1207549","article-title":"eIF4E\u2014from translation to transformation","volume":"23","author":"Mamane","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0950","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.molmed.2007.08.001","article-title":"Targeting the mTOR signaling network in cancer","volume":"13","author":"Chiang","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0955","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","article-title":"PTEN: one gene, many syndromes","volume":"22","author":"Eng","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0960","first-page":"589","article-title":"AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells","volume":"61","author":"Tanno","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0965","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1126\/science.1096502","article-title":"High frequency of mutations of the PIK3CA gene in human cancers","volume":"304","author":"Samuels","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0970","first-page":"2973","article-title":"AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells","volume":"58","author":"Liu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0975","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/gcc.10087","article-title":"Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components","volume":"34","author":"Actor","year":"2002","journal-title":"Gene Chromosome Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0980","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1750-3639.2003.tb00481.x","article-title":"Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3\u2032-kinase\/protein kinase B (Akt) signal transduction pathway in glioblastomas","volume":"13","author":"Knobbe","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0985","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ijc.20711","article-title":"Frequent genetic and biochemical alterations of the PI 3-K\/AKT\/PTEN pathway in head and neck squamous cell carcinoma","volume":"114","author":"Pedrero","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb0990","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2005.11.042","article-title":"PTEN function in normal and neoplastic growth","volume":"241","author":"Chow","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2014.01.008_bb0995","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1165\/rcmb.2004-0355OC","article-title":"A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance","volume":"33","author":"Kim","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1000","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF02573071","article-title":"Phosphatase and tensin analog gene overexpression engenders cellular death in human malignant mesothelioma cells via inhibition of AKT phosphorylation","volume":"9","author":"Mohiuddin","year":"2002","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","article-title":"Exploratory analysis of activation of PTEN\u2013PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","volume":"77","author":"Cedr\u00e9s","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4161\/cc.9.3.10599","article-title":"Hot-spot mutations in p110alpha of phosphatidylinositol 3-kinase (pI3K): differential interactions with the regulatory subunit p85 and with RAS","volume":"9","author":"Zhao","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tibs.2007.05.005","article-title":"Cancer-specific mutations in phosphatidylinositol 3-kinase","volume":"32","author":"Vogt","year":"2007","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/cncr.25555","article-title":"Activation of the phosphoinositide-3-kinase and mammalian target of rapamycin signaling pathways are associated with shortened survival in patients with malignant peritoneal mesothelioma","volume":"117","author":"Varghese","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1470-2045(04)01492-5","article-title":"Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development","volume":"5","author":"Fennell","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1030","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1158\/1535-7163.MCT-06-0269","article-title":"Inhibition of phosphatidylinositol-3-kinase and mitogen-activated protein kinase kinase 1\/2 prevents melanoma development and promotes melanoma regression in the transgenic TPRas mouse model","volume":"5","author":"Bedogni","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1035","first-page":"809","article-title":"Suppression of Pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126","volume":"26","author":"Cole","year":"2006","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1040","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1074\/jbc.M709698200","article-title":"Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids","volume":"283","author":"Barbone","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/BST0350245","article-title":"Chemically targeting the PI3K family","volume":"35","author":"Knight","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1050","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1055","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1158\/0008-5472.CAN-04-0343","article-title":"Akt\/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1440-1843.2004.00602.x","article-title":"Mesothelial cell proliferation and apoptosis","volume":"9","author":"Leard","year":"2004","journal-title":"Respirology"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1070","first-page":"L165","article-title":"Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax","volume":"275","author":"Narasimhan","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1075","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.290.5493.989","article-title":"Role of BAX in the apoptotic response to anticancer agents","volume":"290","author":"Zhang","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.0022-202x.2001.01409.x","article-title":"The Bax\/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95\/Fas-mediated apoptosis","volume":"117","author":"Raisova","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4161\/cbt.6.2.3626","article-title":"Bcl2\/bcl-xL inhibitor engenders apoptosis and increases chemosensitivity in mesothelioma","volume":"6","author":"Cao","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1090","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1736","article-title":"Promoting apoptosis as a strategy for cancer drug discovery","volume":"5","author":"Fesik","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1165\/ajrcmb.25.5.4539","article-title":"Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma","volume":"25","author":"Cao","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1067\/mtc.2002.121684","article-title":"Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product","volume":"123","author":"Smythe","year":"2002","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ijc.23452","article-title":"Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts","volume":"123","author":"Littlejohn","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1110","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/carcin\/bgq026","article-title":"Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy","volume":"31","author":"Varin","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-4598-12-42","article-title":"The novel BH3 alpha-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein\u2013protein interactions with Bak","volume":"12","author":"Cao","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1593\/tlo.08133","article-title":"Proteasome inhibitor MG132 induces apoptosis and inhibits invasion of human malignant pleural mesothelioma cells","volume":"1","author":"Yuan","year":"2008","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1125","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbcan.2012.06.005","article-title":"Merlin: the wizard requires protein stability to function as a tumor suppressor","volume":"1826","author":"Morrow","year":"2012","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1083\/jcb.126.2.391","article-title":"ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons","volume":"126","author":"Tsukita","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138920310791824011","article-title":"Merlin, a \u201cMagic\u201d linker between the extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival","volume":"11","author":"Stamenkovic","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1140","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L","volume":"101","author":"Rong","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1145","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/Merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1150","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","article-title":"Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin","volume":"177","author":"Curto","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2008.08.014","article-title":"Functional inactivation of NF2\/merlin in human mesothelioma","volume":"64","author":"Thurneysen","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1160","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1093\/carcin\/bgn200","article-title":"YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation","volume":"29","author":"Yokoyama","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1165","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1146\/annurev.cellbio.20.010403.113126","article-title":"The WNT signaling pathway in development and disease","volume":"20","author":"Logan","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Klaus","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1175","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/2-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1180","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1038\/sj.onc.1207881","article-title":"Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma","volume":"23","author":"Lee","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1185","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.bbrc.2006.02.084","article-title":"Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma","volume":"342","author":"Batra","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1190","first-page":"423","article-title":"Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma","volume":"24","author":"Kohno","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1195","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.1458","article-title":"Cadherins, catenins and APC in pleural malignant mesothelioma","volume":"201","author":"Abutaily","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1200","first-page":"742","article-title":"Beta-catenin expression in benign and malignant pleural disorders","volume":"4","author":"Anani","year":"2011","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2013.09.025","article-title":"Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells","volume":"440","author":"Fox","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1210","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3892\/etm.2012.511","article-title":"Intratumoral Wnt2B expression affects tumor proliferation and survival in malignant pleural mesothelioma patients","volume":"3","author":"Kobayashi","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1215","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ijc.21160","article-title":"Wnt2 as a new therapeutic target in malignant pleural mesothelioma","volume":"117","author":"Mazieres","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1220","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1476-5586(04)80048-4","article-title":"A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells","volume":"6","author":"He","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1225","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/dc.20281","article-title":"The expression pattern of \u03b2-catenin in mesothelial proliferative lesions and its diagnostic utilities","volume":"33","author":"Dai","year":"2005","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1235","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1349-7006.2006.00386.x","article-title":"Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32","volume":"98","author":"Taniguchi","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1240","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","article-title":"Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients","volume":"97","author":"Usami","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1245","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/arpa.2012-0108-OA","article-title":"p16 deletion in sarcomatoid tumors of the lung and pleura","volume":"137","author":"Tochigi","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1250","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cncy.21269","article-title":"Morphology of 9p21 homozygous deletion-positive pleural mesothelioma cells analyzed using fluorescence in situ hybridization and virtual microscope system in effusion cytology","volume":"121","author":"Matsumoto","year":"2013","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.bbcan.2014.01.008_bb1255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<238::AID-GCC9>3.0.CO;2-M","article-title":"Frequent mutations of NF2 and allelic loss from chromosome band 22q12 in malignant mesothelioma: evidence for a two-hit mechanism of NF2 inactivation","volume":"24","author":"Cheng","year":"1999","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.bbcan.2014.01.008_bb1260","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6","article-title":"Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene","volume":"77","author":"Deguen","year":"1998","journal-title":"Int. J. Cancer"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X14000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X14000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T03:11:28Z","timestamp":1565147488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X14000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":252,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0304419X14000158"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2014.01.008","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2014.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}